PENZBERG, Germany--(BUSINESS WIRE)--To date, more than 125 peer-reviewed studies using Roche’s (SWX:RO)(SWX:ROG)(Pink Sheets:RHHBY) xCELLigence System have been published, spanning a diverse group of applications, including cell invasion and migration of cancer cells (1), receptor activity assays (2), compound induced cytotoxicity (3), antibody-dependent cellular cytotoxicity (4), virus-mediated cytopathogenicity (5) and others (6). The fields of research included toxicology, drug discovery, receptor biology, cancer research, inflammation, neurobiology, among others and are complemented by numerous review articles on the current uses and future potential of the xCELLigence System.
